NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

COVID-19

Expand for resources

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Detailed information for selected cell line:

Cell Line:	Lis15_t(1;12); abnormal karyotype
NIH Registration Number:	0341
NIH Approval Number:	NIHhESC-15-0341
Available for Distribution:	Yes
Provider Restrictions:	MTA and Tel Aviv Medical Center IRB amendment required
Additional Information:	Cell line karyotype: translocation (1;12)
NIH Restrictions:	NIH-funded research with this line is limited to research related to the translocation (1,12), consistent with the language from the informed consent document.
Submitting Organization:	Tel Aviv Sourasky Medical Center
Provider Name:	Dalit Ben-Yosef
Provider Phone:
Provider Email:	dalitb@tlvmc.gov.il
Provider URL:	https://www.tasmc.org.il/sites/en/Research/Tech-Transfer/Stem-Cell-Research-laboratory/Pages/Stem-Cell-Research-laboratory.aspx
Approval Date:	07/16/2015

Related Resources

hESC Line Listings:

NIH Form 2890:

Stem Cell Information:

RSS Feed:

Contact Us: